BioTek Instruments, Inc., continues their global expansion in the microplate-based technology market with the establishment of BioTek Japan.

Managed by Mr. Satoshi Sagara, the new direct sales and service organization in Tokyo will focus on growing BioTek's brand and expanding the sales network in Japan.

BioTek Japan will be fully functional by July 1, 2013. Long-time partner and distributor, DS Pharma Biomedical Co., Ltd., will work closely with BioTek Japan to ensure a seamless transition. BioTek Japan will continue to work with existing distributor, Central Scientific Comm., Inc., to grow the Japanese business.

"The establishment of BioTek Japan will allow BioTek to increase our presence in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing local service and application support, our customers in Japan will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced customer satisfaction for our Japanese customers."

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, North American New Product Innovation Award for Workflow Solutions in Life Sciences and Drug Discovery Product of the Year – Scientists' Choice Award. 

more about BioTek Instruments 

more news from BioTek Insturments